CD44 expression at the invasive tumor front: effect on patterning and prognosis in head and neck cancer

CD44 expression at the invasive tumor front: effect on patterning and prognosis in head and neck... Purpose The invasive tumor front (ITF) and pattern of invasion (POI) are significant prognosticators in head and neck cancer squamous cell carcinoma (HNSCC); this study evaluates the expression of CSC marker, CD44 at the ITF and their combined prognostic potential. Methods POI, as scored by the invasive pattern grading score (IPGS), was correlated with CD44 expression in HNSCC cell line-derived xenografts. Immunohistochemical expression of CD44 was correlated with the ITF features in patients and their combined prognostic ability assessed by multivariate analysis, Kaplan–Meier plots, and Cox regression models. Results Assessment of cell line-derived in vivo models indicated that drug-resistant, CD44-enriched cell lines led to genera- tion of xenografts with aggressive POIs (IV) at the ITF. In patients (N = 173), a near significant association of CD44 with IPGS (p = 0.05) was observed. CD44 (p = 0.02), along with differentiation ( p = 0.04), and lymphoplasmocytic infiltration (LPI) (p = 0.03) were independent prognosticators of recurrence. Notably, IPGS and poorly differentiated tumors were high low predictors of recurrence in CD44 cohort (p < 0.05), while severe LPI was a good prognosticator only in CD44 cohort (p < 0.006). In the treatment naïve cohort, the prognostic efficacy was confined to the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oral Cancer Springer Journals

Loading next page...
 
/lp/springer_journal/cd44-expression-at-the-invasive-tumor-front-effect-on-patterning-and-p8dbJnLUTW
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Dentistry; Dentistry; Oral and Maxillofacial Surgery; Oncology
eISSN
2509-8837
D.O.I.
10.1007/s41548-018-0008-x
Publisher site
See Article on Publisher Site

Abstract

Purpose The invasive tumor front (ITF) and pattern of invasion (POI) are significant prognosticators in head and neck cancer squamous cell carcinoma (HNSCC); this study evaluates the expression of CSC marker, CD44 at the ITF and their combined prognostic potential. Methods POI, as scored by the invasive pattern grading score (IPGS), was correlated with CD44 expression in HNSCC cell line-derived xenografts. Immunohistochemical expression of CD44 was correlated with the ITF features in patients and their combined prognostic ability assessed by multivariate analysis, Kaplan–Meier plots, and Cox regression models. Results Assessment of cell line-derived in vivo models indicated that drug-resistant, CD44-enriched cell lines led to genera- tion of xenografts with aggressive POIs (IV) at the ITF. In patients (N = 173), a near significant association of CD44 with IPGS (p = 0.05) was observed. CD44 (p = 0.02), along with differentiation ( p = 0.04), and lymphoplasmocytic infiltration (LPI) (p = 0.03) were independent prognosticators of recurrence. Notably, IPGS and poorly differentiated tumors were high low predictors of recurrence in CD44 cohort (p < 0.05), while severe LPI was a good prognosticator only in CD44 cohort (p < 0.006). In the treatment naïve cohort, the prognostic efficacy was confined to the

Journal

Oral CancerSpringer Journals

Published: Apr 16, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off